contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


short-term-results-and-long-term-durability-after-corethermr-treatments-presented-at-the-emirates-international-urological-conference-in-dubai-uae

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

ProstaLund

On October 4th, Dr. Dag Sandblom, MD, Consultant Urologist from Sweden, presented short-term results and long-term durability of CoreTherm® treatments at the Emirates International Urological...

<div class="mfn-preamble"><p><strong>On October 4th, Dr. Dag Sandblom, MD, Consultant Urologist from Sweden, presented short-term results and long-term durability of CoreTherm® treatments at the Emirates International Urological Conference 2024, held in Dubai, United Arab Emirates. The data were compiled from patients treated in Sweden at Capio Specialistcenter Solna, Region Stockholm, and Capio Läkargruppen Örebro.</strong></p></div><div class="mfn-body"><p>Since August 2020, a total of 720 patients have undergone CoreTherm® treatment at these centers. This first analysis included 132 patients, demonstrating effective symptom relief with an IPSS (International Prostate Symptom Score) reduction from 24.6 to 8.2. The Bother Score (the quality-of-life impairment domain of the IPSS) was reduced from 4.2 to 1.6, and residual urine was significantly reduced. Approximately 70% of patients were catheter-free after 4 weeks, and 80% were satisfied with the treatment results after 4 months. The favourable outcomes observed after 4 months appear to remain stable throughout the 12–36-month follow-up period.</p><p>The average age of the patients was 75.6 years (ranging from 52 to 96 years), with an average prostate volume of 60 cc (ranging from 24 to 290 cc). The average treatment time was 9 minutes.</p><p>The authors of the abstract concluded that transurethral microwave thermotherapy with CoreTherm® provides durable symptom relief and may save older men from permanent catheter use.</p></div><div class="mfn-footer mfn-43458186cf95"><p><strong class="mfn-heading-1">For further information, please contact:</strong></p><hr><p>Anders Kristensson,&nbsp;CEO<br>Tel. +46 (0) 769 42 12 16<br>Email: anders.kristensson@prostalund.com</p></div><div class="mfn-footer mfn-3ac97e60f473"><p><strong class="mfn-heading-1">About CoreTherm®</strong></p><hr><p>CoreTherm® is a minimally invasive transurethral microwave thermotherapy for benign prostatic enlargement (BPE). The treatment is performed in an outpatient setting under local anaesthesia and takes less than 15 minutes. No general anaesthesia or spinal block is needed. Follow-up data five years after CoreTherm® treatment shows clinical outcomes comparable to those seen after surgery/TURP (transurethral resection of the prostate), but with lower risk of serious complications. For more information visit, <a rel="noopener" href="http://www.coretherm.com">www.coretherm.com</a>.</p></div><div class="mfn-footer mfn-about mfn-6fe429febaf6"><p><strong class="mfn-heading-1">About ProstaLund</strong></p><hr><p>ProstaLund AB (publ) is a Swedish medtech company headquartered in Lund that develops and markets innovative products for the treatment of Benign Prostatic Enlargement (BPE). The company has patented the CoreTherm® Concept, a customised thermal treatment for BPE. ProstaLund is listed on Nasdaq First North Growth Market and has approximately 3,600 shareholders. For more information, visit <a rel="noopener" href="http://www.prostalund.se">www.prostalund.se</a>. Our press releases are also available to read and download here: <a rel="noopener" href="http://www.prostalund.se/pressmeddelanden">www.prostalund.se/pressmeddelanden</a></p><p><strong>Certified Adviser</strong>:<br>Västra Hamnen Corporate Finance AB<br>Phone: +46 40 200 250<br>E-mail: <a rel="noopener" href="mailto:ca@vhcorp.se">ca@vhcorp.se</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/3848a019-d65d-4ddc-a8ca-253da6aaa37e/short-term-results-and-long-term-durability-after-coretherm-r-treatments-presented-at-the-emirates-international-urological-conference-in-dubai-uae.pdf" class="mfn-generated mfn-primary">Short-term results and long-term durability after CoreTherm® treatments presented at the Emirates International Urological Conference in Dubai, UAE</a></p></div>

Short-term results and long-term durability after CoreTherm® treatments presented at the Emirates International Urological Conference in Dubai, UAE